All News
New Technology + More Resources = More Empowered Primary Care Physicians
(MedPage Today) -- Give us enough resources, and the right resources, and we can do just about anything -- and just about everything.
Read MoreFDA Approves First Drug for Classic Congenital Adrenal Hyperplasia in 70 Years
(MedPage Today) -- The FDA approved crinecerfont (Crenessity) as a first-in-class treatment for classic congenital adrenal hyperplasia (CAH), the agency announced late Friday.
Read MoreCDC Can't Confirm Suspected Bird Flu Case Tied to Raw Milk
(MedPage Today) -- CDC could not confirm what was suspected to have been the first H5N1 bird flu case linked to raw milk consumption.
Read MoreLonger Admissions for IBD Flares Linked to VTE Risk
(MedPage Today) -- ORLANDO -- Longer hospitalization for flares of inflammatory bowel disease (IBD) was linked to greater risk of subsequent venous thromboembolism (VTE) independent of other risk f
Read MoreCosibelimab OK'd for Cutaneous Squamous Cell Carcinoma
(MedPage Today) -- The FDA approved cosibelimab (Unloxcyt) for treating metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC) in adults who are not candidates for curative surgery o
Read MoreSTAT+: The AI denial fighters and health care’s rising profitability
This week in healthcare business news: Using AI to fight insurance denials, Centene backs insurance subsidies, and the latest on Luigi Mangione.
Read MoreFDA Approves New IL-31 Drug for Eczema
(MedPage Today) -- The FDA approved nemolizumab (Nemluvio) in combination with prescription topical agents for the treatment of moderate-to-severe atopic dermatitis, drugmaker Galderma announced.
Read MoreNewer Diabetes Drugs Still Under-Prescribed in High-Risk Patients
(MedPage Today) -- NEW ORLEANS -- Patients at a community health center who had type 2 diabetes and a high risk of atherosclerotic cardiovascular disease (ASCVD) were under-prescribed guideline-rec
Read MoreBenefits of Drug Combo in Myeloma Maintenance Shown in Relevant Subgroups
(MedPage Today) -- A post hoc analysis of the phase III AURIGA study showed that the addition of daratumumab (Darzalex) to lenalidomide (Revlimid) for multiple myeloma in the post-transplant maintena
Read MoreSTAT+: FDA authorizes many AI devices for use in kids. Are they validated in a pediatric population?
A new study resurfaces long-simmering concerns about the lack of transparency in data used to train and validate AI and ML-enabled devices.
Read More